T1	intervention 35 73	wearable technology-based intervention
T2	No-of-participants 731 733	83
T3	eligibility 734 841	inactive, postmenopausal women diagnosed with stage I-III breast cancer who had completed primary treatment
T4	control 915 928	control group
T5	duration 972 979	12-week
T7	No-of-participants 1169 1171	80
T6	outcome-Measure 988 992	MVPA
T8	outcome-Measure 997 1015	sedentary behavior
T9	outcome 1401 1477	decrease in both total sitting time and prolonged bouts (≥20 min) of sitting
T10	outcome 1244 1288	significant between-group difference in MVPA
